Lys154 is the only positively charged residue located in the VLPQGWK motif on the b8±aE loop at the junction of the ®ngers and palm subdomains of human immunode®ciency virus type 1 reverse transcriptase (HIV-1 RT). Some of the conserved residues in this motif are critical for RT function, while others have been shown to confer nucleoside drug resistance and ®delity to the enzyme. In order to understand the functional implication of this positively charged residue, we carried out site-directed mutagenesis at position 154 and biochemically characterized the mutant enzymes. Mutants carrying negatively charged side chains (K154D and K154E) were severely impaired in their polymerase function, while those with hydrophobic side chains (K154A and K154I) were moderately affected. Analysis of the binary complexes formed by these mutants revealed that all the mutant derivatives retained their ability to form an enzyme template primer (E±TP) binary complex similar to the wild-type enzyme. In contrast, their ability to form stable E±TP±dNTP ternary complexes varied greatly and was dependent on the nature of the side chain at position 154. The conservative Lys®Arg mutant was not affected in its ability to form a stable ternary complex, while those carrying non-polar or negatively charged side chains were signi®cantly impaired. The apparent K d [dNTP] values for these non-conservative mutants were~16-to 400-fold higher than the wild-type enzyme, indicating that a positively charged side chain at position 154 may be required for ef®cient formation of a stable ternary complex. Interestingly, all the mutant derivatives of Lys154 were completely resistant to a nucleoside analog inhibitor, 3¢-dideoxy 3¢-thiacytidine (3TC), implying that Lys154 may play a role in conferring 3TC sensitivity to HIV-1 RT. These ®ndings are discussed in the context of the binary and ternary complex crystal structures of HIV-1 RT.
INTRODUCTION
Human immunode®ciency virus type 1 reverse transcriptase (HIV-1 RT) is a virally encoded enzyme essential for viral replication and establishing HIV-1 infection. This enzyme copies the single-stranded HIV-1 RNA genome into doublestranded proviral DNA which is subsequently integrated into the host genome. RT is one of the two enzyme targets against which drugs are currently employed to reduce the viral load in plasma, the other being HIV-1 protease. HIV-1 RT is a heterodimeric enzyme consisting of 66 and 51 kDa polypeptides (p66/p51). The p51 subunit lacking the C-terminal 15 kDa RNase H domain is the proteolytic cleavage product of the larger p66 subunit (1, 2) .
HIV-1 RT is a highly error-prone enzyme which probably contributes to the genetic diversity of HIV-1 (3±5). Various nucleoside drug resistance phenotypes have been identi®ed in clinical isolates from patients exposed to RT inhibitors. A single natural mutation at codon 151 (Gln®Met) of HIV-1 RT confers resistance to all nucleoside inhibitors (6±8). Gln151 is a constituent of the relatively conserved VLPQGWK sequence of HIV-1 RT. This motif is a component of motif B found in all retroviral RTs and is located on the b8±aE loop at the junction of the ®ngers and palm subdomains of HIV-1 RT. Four of the seven residues in this sequence are highly conserved residues designated as the LPQG motif, which plays an important role in dNTP binding and in positioning the duplex DNA in the catalytic pocket of HIV-1 RT. Gln151 is an important component of the dNTP-binding pocket (9±13) and has been proposed to stabilize the side chain of Arg72, a participant in the conformational change step of the ternary complex during catalysis (10, 14) . Two residues preceding Q151, namely L149 and P150, have been shown to be crucial for the enzyme function (15) . Gly152, the residue following Gln151, has been demonstrated to be absolutely essential for the polymerase function (13±15).
Lys154, a constituent of the larger VLPQGWK motif B, is the only positively charged residue in this motif and has been shown to in¯uence the processivity and ®delity of HIV-1 RT (13) . In the present study, we have evaluated the signi®cance of this positively charged residue in the catalytic function of HIV-1 RT. All the non-conservative mutant derivatives of Lys154 were moderately to severely impaired in their polymerase function and in their ability to form stable ternary complex, though they retained full wild-type binding af®nity for the template primer (TP). Interestingly, all the mutant derivatives of Lys154 were resistant to (±)-b-2¢,3¢-dideoxy3¢-thiacytidine triphosphate (3TCTP), suggesting that Lys154 may be one of the residues involved in conferring 3TC susceptibility to HIV-1 RT. These results are discussed in the context of the binary and ternary complex crystal structures of HIV-1 RT.
MATERIALS AND METHODS

Materials
Restriction endonucleases and DNA-modifying enzymes were obtained from Promega. HPLC-puri®ed ultrapure dNTPs, Sequenase and DNA sequencing reagents were from Roche Molecular Systems, Inc. The [a-32 P]dNTPs and [g-32 P]ATP were obtained from PerkinElmer Life Sciences. Synthetic TPs, sequencing primers and mutagenic oligonucleotides were synthesized at the Molecular Resource Facility at the University of Medicine and Dentistry of New Jersey. All other reagents were of the highest available purity grade and were purchased from Roche Molecular Systems, Inc., Fisher or Bio-Rad.
Expression of plasmid clones and in vitro mutagenesis
The recombinant HIV-1 RT was expressed and puri®ed as described before (16±19). The QuikChangeÔ Site-Directed Mutagenesis Kit from Stratagene was employed to generate the mutant clones using two primers corresponding to the sense and antisense strands containing the desired mutation, and ascertained by DNA sequencing.
Preparation of the HIV-1 U5-PBS RNA template
The HIV-1 genomic RNA template corresponding to the primer-binding sequence region (U5-PBS HIV-1) was prepared using an HIV-1 RNA expression clone (pHIV-PBS) as described previously (17, 20) . The plasmid pHIV-PBS was linearized with AccI and transcribed using T7 RNA polymerase according to the manufacturer's protocol (Gibco-BRL).
Polymerase activity assay
Polymerase activity of the wild-type and mutant enzymes was assayed on heteropolymeric U5-PBS HIV-1 RNA±DNA and homopolymeric poly(rA) templates primed with the respective complementary DNA primers (12, 17) . Assays were carried out in a ®nal volume of 50 ml containing 15 nM enzyme in 50 mM Tris±HCl pH 7.8, 100 mg/ml bovine serum albumin (BSA), 5 mM MgCl 2 , 10 mM dithiothreitol (DTT), 60 mM KCl, 100 nM TP, 20 mM of each dNTP containing a-32 Plabeled dCTP and dGTP (0.5 mCi/nmol) with heteropolymeric template or 20 mM TTP containing [a-32 P]dTTP (0.5 mCi/nmol) with the homopolymeric poly(rA) template. Reactions were initiated by the addition of divalent metal ion (Mg 2+ , 5 mM), incubated at 37°C for 3 min and terminated by the addition of ice-cold 5% trichloroacetic acid containing 5 mM inorganic pyrophosphate. The acid-insoluble radioactive material was collected on Whatman GF/B ®lters, dried and counted for radioactivity in a Packard Tricarb Liquid Scintillation Counter.
Dissociation constant of enzyme±DNA binary complex
The dissociation constants (K d ) of the enzyme (E)±TP binary complexes of the wild-type HIV-1 RT and its mutant derivatives were determined as described before (18) . The 33mer DNA template (5¢-TGC GCG TTA TAC GGC ACT TCG GAG TGG CTA ACG-3¢) primed with 5¢-32 P-labeled dideoxy-terminated 21mer primer (5¢-CGT TAG CCA CTC CGA AGT GC dd C-3¢) was used in these binding studies. Varying concentrations of the individual enzymes were incubated with 0.3 nM TP in a total volume of 10 ml containing 50 mM Tris±HCl pH 7.8, 5 mM MgCl 2 and 0.01% BSA. An equal volume of 2Q gel loading dye (0.25% bromophenol blue, 20% glycerol) was added after 10 min incubation at 4°C, and the E±TP binary complexes were resolved by electrophoretic mobility shift assay (EMSA) and analyzed on a phosphorImager. The percentage of the labeled TP bound to the enzyme (E±TP binary complex) versus enzyme concentrations was plotted and the dissociation constant, K d [DNA] , was determined as the enzyme concentration at which half-maximum DNA binding occurred.
Formation of stable ternary (E±TP±dNTP) complex and determination of dNTP binding af®nity (apparent
The ability of HIV-1 RT and its mutant derivatives to form a stable ternary complex was evaluated as described by Tong et al. (21) . For this purpose, the individual enzyme protein (10±50 nM) was incubated with the labeled 33/21 ddC TP to form the binary complex and then further incubated at 4°C for 10 min in the presence of 200 mM dGTP, a nucleotide complementary to the ®rst template base. The incubation buffer (10 ml) contained 50 mM Tris±HCl pH 7.8, 5 mM MgCl 2 and 0.01% BSA. The putative ternary complexes formed were challenged by the addition of 300-fold molar excess of the unlabeled 33/21 ddC TP. The ternary complex species resistant to the DNA trap were resolved on a 6% native polyacrylamide gel, subjected to phosphorimaging and quanti®ed using ImageQuant Software.
Determination of the apparent dNTP binding af®nity (apparent K d [dNTP] ) of the wild-type enzyme and its mutant derivatives was carried out as described above except that the binary complexes were incubated in the presence of increasing concentrations of the complementary nucleotide (dGTP, 0± 4000 mM) prior to being challenged by the DNA trap. The E±TP±dNTP ternary complexes resistant to the trap were resolved and quanti®ed as above. The apparent K d [dNTP] was determined from the percentage of total E±TP binary complex converted into the stable E±TP±dNTP ternary complex as a function of dNTP concentration by ®tting the data to the single-site ligand-binding equation using Sigma Plot.
RESULTS
Construction and puri®cation of Lys154 mutants
Five different mutants of Lys154 were generated by sitedirected mutagenesis as described before (16) . The positively charged Lys154 was replaced either by non-polar uncharged alanine or isoleucine, by negatively charged aspartate and glutamate or by the positively charged guanidino side chain of arginine. The mutant enzymes were puri®ed to near homogeneity (>98% purity) and stored at ±80°C in 50% glycerol containing 50 mM HEPES pH 7.0, 1 mM DTT and 100 mM NaCl.
Impact of substitution at position 154 on the DNA polymerase function of the enzymes Heteropolymeric RNA and DNA as well as homopolymeric poly(rA) templates were used to examine the impact of these mutations on the DNA polymerase activity of the enzyme. The results shown in Table 1 are expressed as percentage polymerase activity relative to the wild-type enzyme. The conservative Lys®Arg substitution at position 154 slightly enhanced the polymerase activity of the enzyme, while two mutant derivatives carrying a non-polar hydrophobic side chain (K154A and K154I) retained~50±73% polymerase activity on all templates. In contrast, mutants with a negatively charged side chain (Lys®Asp and Lys®Glu) were impaired, exhibiting 9±29% polymerase activity.
Formation of E±TP binary and E±TP±dNTP ternary complexes
These results suggest that a positively charged side chain at position 154 may not be crucial for the polymerase function of the enzyme since Lys®Ala and Lys®Ile substitution retained 50±70% polymerase activity. In contrast, a negatively charged side chain at this position seems to be unfavorable for polymerase function of the enzyme. Since, in the crystal structure of HIV-1 RT±DNA±dNTP ternary complex, Lys154 is seen interacting with the DNA phosphate backbone (22) , it may be reasonable to infer that a negative charge at this position may interfere with the DNA-binding function of the enzyme. To investigate this possibility, the K d (DNA) in the E±TP binary complex for the wild-type enzyme and its mutant derivatives was determined by EMSA. The results of this analysis are shown as an inset table in Figure 1 along with representative data obtained with the wild-type and K154R mutant enzymes. Interestingly, all the conservative and nonconservative mutant derivatives of Lys154 had no in¯uence on the formation of E±TP binary complex. In fact, a slightly enhanced DNA binding af®nity was noted for some of the mutants.
These results suggest that the polar or non-polar nature of the side chain at position 154 has no in¯uence on the formation of E±TP binary complex. In the crystal structure of E±TP binary and E±TP±dNTP ternary complexes, the side chain conformation of Lys154 is dissimilar (22±24). In the binary complex, it mainly interacts with Asp86 and Gln85 which are located away from the TP-binding track (23, 24) while, in the ternary complex, it interacts directly with the penultimate template nucleotide in the duplex region (22) . Therefore, the reduction in the polymerase activity observed with some of the mutant derivatives of Lys154 may be due to Figure 2 , substitutions at position 154 had no in¯uence on the formation of E±TP binary complex but seem to have major impact on stabilizing the E±TP±dGTP ternary complexes. Similar patterns were also obtained with dATP and dTTP when the corresponding ®rst template base was dT and dA, respectively (data not shown). Since Lys154 of HIV-1 RT is not seen interacting directly with dNTP in the crystal structure of the ternary complex, its in¯uence on stabilizing the dNTP in the ternary complex was particularly interesting. Although the side chain of Lys154 does not interact with DNA in the binary complex (23, 24) , it establishes direct contact with the duplex region of the DNA in the ternary complex (22) . This interaction between the positively charged Lys154 and negatively charged phosphate group of DNA may be required to stabilize the latter in the ternary complex. The negatively charged side chain at this position (K154D and K154E) may destabilize the TP in the ternary complex due to charge repulsion. We therefore assert that the negative impact of K154D and K154E mutants on the formation of stable ternary complex may be due to their destabilizing effect on the TP rather than to interference in the dNTP binding per se. In this scenario, apparent dNTP binding af®nity in the ternary complex may be greatly affected due to unstable transition of binary complexes into ternary complexes. This postulation was explored by determining the apparent dNTP binding af®nity of individual mutant derivatives of Lys154. The results are shown as an inset table in Figure 3 . Representative data depicting the ternary complex formation as a function of varying concentration of dGTP by the wild-type enzyme and K154A mutant are shown in Figure 3 . A 16-to 320-fold reduction in the apparent dGTP binding af®nity was noted with those mutants carrying uncharged or negatively charged side chains, suggesting that the reduced polymerase activity observed with these mutants may be attributable to unstable ternary complex formation. Since binding af®nity of the mutant enzymes for dNTP and the extent of their ternary complex formation are intrinsically linked, a correlation of these parameters with their polymerase activity is clearly established. The conserved Lys®Arg mutant carrying a positively charged guanidino side chain exhibited apparent dNTP binding af®nity similar to the wild-type enzyme.
TP binding af®nity in the presence and absence of dNTP
The binding of TP and dNTP to HIV-1 RT follows an ordered mechanism where dNTP binding occurs only after the binding of TP to the enzyme (25±27). It is expected that improper binding/orientation of the TP may also affect the binding of dNTP to the E±TP binary complex. It is therefore unlikely that dNTP binding in the ternary complex may in¯uence the af®nity of the enzyme for the TP. In order to rule out this possibility, we have determined DNA binding af®nity of the wild-type and mutant enzymes in the presence or absence of dNTP. Under both these conditions, no signi®cant differences in their K d (DNA) were noted (data not shown).
Sensitivity to nucleotide analogs
Since Lys154 is in the vicinity of Gln151 and Glu89, which are involved in conferring sensitivity to various nucleoside analogs (6±8,28), we also examined the sensitivity of Lys154 mutants to 3TCTP, an inhibitor of HIV-1 RT. Interestingly, all the mutant derivatives of Lys154 were resistant to 3TCTP, suggesting that Lys154 may be one of the residues involved in conferring 3TC susceptibility to RT (Fig. 4) . The 3TCTP-resistant phenotype observed with the conservative K154R mutant was unexpected. We therefore examined the sensitivity of the K154R mutant to other nucleotide analogs and found that it is comparatively less sensitive to all the four ddNTPs (Fig. 5) . So far, no naturally occurring drug-resistant mutation has been reported at this conserved position. This residue lies in the vicinity of Glu89 and Gln151, mutant derivatives of which have been shown to exhibit cross resistance phenotype to dNTP analogs (7, 29) .
DISCUSSION
Lys154 located on the b8±aE loop at the junction of the ®ngers and palm subdomains of HIV-1 RT is the lone positively charged residue in the reasonably conserved VLPQGWK motif. The last four residues of this motif, including Lys154, are constituents of the`template grip' region of HIV-1 RT (22) . Other constituents of the grip region are Asp76, Arg78, Glu89, Gly93 and Ile94 (22) . Two charged residues of this grip region (Asp76 and Arg78) interact directly with the single-stranded region of the template (15, 30) , and their mutant derivatives have been shown to alter DNA binding af®nity of the enzyme (31) . Glu89 interacts with the penultimate template nucleotide in the duplex region of the TP in both binary and ternary complexes (22, 23) and has been shown to be involved in both ®delity and sensitivity to several nucleoside analogs (28, 32, 33) . Another important Figure 4 . Sensitivity of the Lys154 mutants to 3TCTP. The U5-PBS 49mer DNA template primed with 5¢-32 P-labeled 17mer PBS primer was used to analyze the extent of DNA synthesis carried out by the Lys154 mutant derivatives in the presence or absence of 3TCTP. The concentration of each mutant enzyme was normalized to contain polymerase activity equal to the wild-type enzyme. Reactions were carried in the standard reaction mixture containing 10 mM dNTP and 2 mM 3TCTP in a ®nal volume of 5 ml. Following 5 min incubation at 37°C, reactions were terminated by Sanger's gel loading dye and the products were analyzed by denaturing 8% polyacrylamide±8 M urea gel electrophoresis followed by phosphorImaging. The position of the 17mer primer is indicated on the right. The data obtained with two less active mutants derivatives (K154D and K154E) are not shown. residue in the VLPQGWK motif is Gln151, which is also located on the b8±aE loop and has been studied extensively. This residue interacts with both the template and the incoming dNTP substrate (10, 11, 34) and has been implicated in conferring drug sensitivity to HIV (6±8). In the 3D crystal structure of the RT±DNA binary complex (23,24), Lys154 does not make any direct or indirect contact with the bound DNA and therefore may not be involved in the formation of E±TP binary complex. Our gel shift analysis data con®rmed this premise as none of the Lys154 mutant derivatives showed any reduction in their DNA binding af®nity. However, their polymerase activity varied signi®cantly depending upon the nature of their side chain at position 154. The hydrophobic side chain of alanine or isoleucine at this position allowed the enzyme to retain 50±70% of the wild-type activity, while mutants carrying negatively charged side chains were signi®cantly impaired in their polymerase activity, retaining only 9±29% of the wild-type activity (Table 1) . These results suggest that Lys154 may have a pertinent role only after the formation of E±TP binary complexes. This premise was examined by monitoring the next step of dNTP binding to E±TP binary complexes of individual Lys154 mutant derivatives. Since proper positioning of the TP during the transition of binary complex to ternary complex is a prelude to the formation of stable and productive ternary complexes, a subtle change in the position of the TP will greatly impact the stability of the E±TP±dNTP ternary complex. It was observed that all the mutant derivatives of Lys154, except K154R, are signi®cantly affected in their ability to form stable ternary complexes (Fig. 2) . This effect was more pronounced with mutant derivatives carrying a negatively charged side chain (K154D and K154E) at this position. The apparent dNTP binding af®nity was signi®cantly decreased in the case of all non-conservative mutants of Lys154, suggesting the possibility of an improper positioning of TP at their active site (Fig. 3) . This implies that Lys154 may speci®cally be involved only after the initial TP binding step. To understand these interactions at the structural level, we examined the apo, binary and ternary complex crystal structures of HIV-1 RT. It was observed that Lys154 adapts distinctly different conformations in these structures (Fig. 6 ). In the ternary complex, the side chain of Lys154 (green) interacts with the phosphate atom of the penultimate template nucleotide in the duplex region from the primer terminus. It is also within interacting distance of Glu89, which contacts the sugar moiety of the same template nucleotide. These interactions of Lys154 are not seen in the crystal structure of HIV-1 RT bound to TP (23, 35) . Instead, in the E±TP binary complex, Lys154 (red) forms a salt bridge with the side chain of Asp86 and hydrogen-bonds with the main chain oxygen of Asp86 and Gln85, both of which are away from the TP-binding track and are located at the subunit interface. Similar interactions of Lys154 (magenta) are also seen in the apo-crystal structure (24) of HIV-1 RT. Our results with the mutant derivatives of Lys154 pertaining to the formation of E±TP binary and E±TP± dNTP ternary complexes are in agreement with the interactions seen in the corresponding crystal structures. These observations suggest that Lys154 participates in the formation of a closed ternary complex by maintaining proper positioning of the TP either by itself or in conjunction with Glu89. A drastic reduction in the stable ternary complex formation observed with K154D and K154E mutants could be a direct consequence of repulsion and loss of interaction with the side chain of Glu89.
A puzzling aspect of these results is that all the mutant derivatives of Lys154 are completely resistant to 3TCTP, a nucleoside inhibitor of HIV-1 RT. In the ternary complex, the conformation of the side chain of Lys154 is within interacting Figure 6 . Stereo view of the superimposed crystal structures of HIV-1 RT showing the side chain conformations of Lys154 in the apo, binary and ternary complex structure. The 3D structures of HIV-1 RT in apo form, E±TP binary complex and E±TP±dNTP ternary complex were obtained from PDB ®les 1QE1, 1HYS and 1RTD, respectively. Superposition of the above three forms of the crystal structures, showing the relative orientation of Lys154, was carried out by ®tting the 38 Ca atoms from the palm subdomain from b-strands 6, 9 and 10. The template±primer shown is from the ternary complex structure of HIV-1 RT (PDB ®le 1RTD). The Ca trace (thin line) as well as the side chains of surrounding residues in apo, binary and ternary complex structures are shown in magenta, red and green, respectively. The primer is colored in magenta, while the template is shown in blue. As seen in the structure, the side chain of Lys154 displays different interactions due to subtle changes in its conformation in the three crystal structures.
distance from Glu89, in addition to interacting with the phosphate atom of the penultimate template nucleotide in the duplex region of DNA (Fig. 6, green) . Salt bridge interactions may occur between amino acid side chains with opposite charges when they are within 4 A Ê apart (36, 37) . In the crystal structure of the ternary complex, the distance between N2 (Lys154) and OE2 (Glu89) is 3.65 A Ê , suggesting the possibility of such an interaction between them. A systematic conformation search of the side chain of Lys154 and Glu89 revealed that in one of the conformations, both the side chains face each other. Since salt bridge interactions are not local but long-range interactions, such interaction may be signi®cant in stabilizing the side chain of Glu89. Since Glu89 mutants have been shown to confer resistance to ddNTPs (28, 38) , we postulate that the 3TCTP resistance phenotype of Lys154 mutants may be via Glu89 due to loss of interaction between their side chains.
Why is a conservative K154R mutant not sensitive to 3TCTP? Similarly to Lys154, it should also be able to interact with and stabilize the side chain of Glu89. In order to explain the observed 3TCTP-resistant phenotype of the K154R mutant, we carried out mutant modeling of Lys154 in the ternary complex crystal structure using the Look Modeling package. Unlike Lys154, which assumes two distinct orientations in the binary and ternary complexes, the side chain conformation of Arg154 is similar in both the binary and ternary complexes. In our modeling studies, the guanidino group of Arg154 directly interacts with the phosphate atom of the penultimate template base in the duplex region and also makes a hydrogen bond with Asp86 in both binary and ternary complexes. However, unlike Lys154, it does not seem to interact with and stabilize the side chain of Glu89, which may be one of the factors contributing to its 3TCTP-resistant phenotype.
Amino acid sequence alignment of RTs from different retroviruses shows that Lys154 is fairly well conserved (Fig. 7) . In RTs from HIV-1, HIV-2, simian immunode®ciency virus, visna virus, caprine arthritis encephalitis virus, Moloney murine leukemia virus, human T-cell leukemia virus I and II, and mouse mammary tumor virus, Lys154 is absolutely conserved, whereas in others it is replaced by smaller side chain such as valine, isoleucine, threonine and alanine. Interestingly, of the two residues proposed to be involved in salt bridge interactions with Lys154 (Asp86 and Glu89), Asp86 is always present along with Lys154, except in HTLV-II which has threonine in place of aspartate. In contrast, the concurrent presence of Glu89 is observed only in a few retroviral RTs including HIV-1. Thus, the salt bridge formation property between Lys154, Asp86 and Glu89 seems rather con®ned to this group of RTs. This phenomenon appears to have functional signi®cance since in HIV-1 RT, the E89G mutation has been noted to confer nucleoside drugresistant phenotypes (28, 38) while in other RTs which do not have glutamate at the equivalent position, natural nucleoside resistance is observed. 
